G Medical Innovations Ltd Statistics
Share Statistics
G Medical Innovations Ltd has 9.82M
shares outstanding. The number of shares has increased by 0%
in one year.
| Shares Outstanding | 9.82M |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 164 |
| FTD / Avg. Volume | 0.01% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
| PE Ratio | 0 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | n/a |
| PB Ratio | 0 |
| P/FCF Ratio | 0 |
| PEG Ratio | 0 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for G Medical Innovations Ltd.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.22,
with a Debt / Equity ratio of -0.28.
| Current Ratio | 0.22 |
| Quick Ratio | 0.19 |
| Debt / Equity | -0.28 |
| Debt / EBITDA | -0.06 |
| Debt / FCF | -0.1 |
| Interest Coverage | 1.91 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $52,619.05 |
| Profits Per Employee | $-166,166.67 |
| Employee Count | 84 |
| Asset Turnover | 0.92 |
| Inventory Turnover | 12.45 |
Taxes
| Income Tax | 16K |
| Effective Tax Rate | -0.11% |
Stock Price Statistics
The stock price has increased by 200% in the
last 52 weeks. The beta is -1.08, so G Medical Innovations Ltd's
price volatility has been lower than the market average.
| Beta | -1.08 |
| 52-Week Price Change | 200% |
| 50-Day Moving Average | 0.19 |
| 200-Day Moving Average | 1.37 |
| Relative Strength Index (RSI) | 31.7 |
| Average Volume (20 Days) | 1,237,322 |
Income Statement
In the last 12 months, G Medical Innovations Ltd had revenue of 4.42M
and earned -13.96M
in profits. Earnings per share was 0.
| Revenue | 4.42M |
| Gross Profit | 784K |
| Operating Income | -27.41M |
| Net Income | -13.96M |
| EBITDA | -37.75M |
| EBIT | -30.21M |
| Earnings Per Share (EPS) | 0 |
Full Income StatementBalance Sheet
The company has 295K in cash and 2.09M in
debt, giving a net cash position of -1.8M.
| Cash & Cash Equivalents | 295K |
| Total Debt | 2.09M |
| Net Cash | -1.8M |
| Retained Earnings | -115.26M |
| Total Assets | 4.83M |
| Working Capital | -7.12M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -18.48M
and capital expenditures -2.12M, giving a free cash flow of -20.6M.
| Operating Cash Flow | -18.48M |
| Capital Expenditures | -2.12M |
| Free Cash Flow | -20.6M |
| FCF Per Share | 0 |
Full Cash Flow StatementMargins
Gross margin is 17.74%, with operating and profit margins of -620.14% and -315.79%.
| Gross Margin | 17.74% |
| Operating Margin | -620.14% |
| Pretax Margin | -315.43% |
| Profit Margin | -315.79% |
| EBITDA Margin | -854.1% |
| EBIT Margin | -620.14% |
| FCF Margin | -466.06% |
